Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry therefore keeping a tab on the updated and latest updates and trends concerning the field.
Our widespread and market specific content write-ups cater to Industry professionals intending to keep pace with this dynamic and revolutionary industry. Articles like the latest news, trends, analysis, market reports, press releases, whitepapers, case studies, etc. enable further insight as well as an in-depth interpretation of industry trends.
Our editorial staff is committed to disseminating concise facts and information to its readers and subscribers by collating credible information from known sources and decoding them in the form of innumerable content pieces. Ranging from objective facts to subjective, analytical studies enables a holistic view of the topics scouted for.
It is noteworthy that Pharma Journalist which is a product of Kellen Media also offers a plethora of online marketing services aiding companies and organizations to reach out to targeted audience based on the geographical and demographic profiles ensuring enhanced reach and visibility garnered for their products or events paving way for accentuated brand awareness.
The Antibody Society is an international non-profit association representing individuals and organizations involved in antibody research and development. We are an authoritative source of information about antibody therapeutics development, which we disseminate via our website, webinars, conference presentations and publications. Our members are regularly kept up to date on industry news via our “Antibody News You Should Know”, which summarize relevant events of the past 2 weeks.
We also organize meetings and workshops on topics relevant to antibody research and development. In particular, we actively produce and participate in webinars and workshops designed to educate and inform early-career scientists about antibody research, including best practices for antibody reagent validation. Additionally, the Society’s Adaptive Immune Receptor Repertoire (AIRR) Community coordinates stakeholders using next-generation sequencing technologies to study antibody/B-cell and T-cell receptor repertoires. They are developing: 1) a common repository for AIRR sequence data; 2) standards for publishing and depositing AIRR sequence data; and 3) resources and guidelines for the evaluation of molecular and statistical methods for AIRR sequence data.
The Chinese Antibody Society is a nonprofit professional organization focusing on therapeutic antibodies and relevant therapeutic modalities. Our mission is to build a platform that facilitates the communication and collaboration of the global community in the discovery, development, manufacturing, and commercialization of antibody-based products.